Sunmark Iodine

Iodine, Sodium Iodide, Alcohol


Strategic Sourcing Services Llc
Human Otc Drug
NDC 49348-133
Sunmark Iodine also known as Iodine, Sodium Iodide, Alcohol is a human otc drug labeled by 'Strategic Sourcing Services Llc'. National Drug Code (NDC) number for Sunmark Iodine is 49348-133. This drug is available in dosage form of Tincture. The names of the active, medicinal ingredients in Sunmark Iodine drug includes Alcohol - 470 mg/mL Iodine - 20 mg/mL Sodium Iodide - 24 mg/mL . The currest status of Sunmark Iodine drug is Active.

Drug Information:

Drug NDC: 49348-133
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Sunmark Iodine
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Iodine, Sodium Iodide, Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Strategic Sourcing Services Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tincture
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALCOHOL - 470 mg/mL
IODINE - 20 mg/mL
SODIUM IODIDE - 24 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 28 Jun, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 12 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Strategic Sourcing Services LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0010939157331
UPC stands for Universal Product Code.
UNII:3K9958V90M
9679TC07X4
F5WR8N145C
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
49348-133-2730 mL in 1 BOTTLE (49348-133-27)23 Aug, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Sunmark iodine iodine, sodium iodide, alcohol water iodine iodine alcohol alcohol sodium iodide iodide ion

Indications and Usage:

Uses to help prevent infection in minor cuts, scrapes and burns.

Warnings:

Warnings: for external use only.

Dosage and Administration:

Directions: clean the affected area. apply a small amount to the affected area 1 to 3 times daily. may be covered with a sterile bandage. if bandaged, let dry first.

Package Label Principal Display Panel:

Iodine


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.